Comparison between pain control of 4% articaine buccal infiltration and 2% lignocaine inferior alveolar nerve block for pulpectomy procedure in children of age group of 6-10 years: A randomized controlled clinical trial.
- Conditions
- Health Condition 1: - Health Condition 2: K040- Pulpitis
- Registration Number
- CTRI/2022/11/047411
- Lead Sponsor
- Ruchi Pramod Saple
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Cooperative behavior for dental treatment under local anesthesia (class 3 or 4 in Frankel scale)
2. Children of age group-6 to 10 years
3. No history of allergic reactions to local anesthesia or sulfites
4. No medical conditions contraindicating the use of local anesthetics containing epinephrine
5. No evidence of soft tissue infection/inflammation near the area of injection
6. Not taking any medication that potentially interfere with pain assessment within 24 hours before the treatment
7. No difficulties in communication
1. Patients with allergies to local anesthetics or sulfites
2. History of significant medical conditions
3. Any medications
4. Presence of abscess, sinus opening
5. Uncooperative patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain control during pulpectomy procedure is to be determined after administration of 4 % articaine through buccal infiltration on one side and 2% lignocaine through inferior alveolar nerve block on other side. Evaluation will take place through objective scale using the Modified Behavioural Pain Scale (MBPS) suggested by Taddio et al. This scale includes the facial expression, movement and crying. and subjective scale by WONG-BAKERâ??s Pain Scale (FPS).Timepoint: At baseline with one anesthetic agent and after 2 weeks with another anesthetic agent.
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI